{
  "ptid_time": "941_S_1295_2007-02-09",
  "img_path": "/data/qiuhui/data/adni/images/941_S_1295/2007-02-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 66,213 mm³, 71.9% above the reference mean. With a Z-score of 1.72 (95.8th percentile), this represents moderate enlargement; whole brain volume measures 1,001,320 mm³, 7.2% below the reference mean. With a Z-score of -0.94 (17.4th percentile), this represents normal volume . ",
  "text_data": "Age is 76.7 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Smoking; Major Surgical Procedures. MMSE: 28.0. Logical Memory: 7.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 614.40 pg/mL (mild reduced); Total tau: 390.00 pg/mL (moderate elevated); Phosphorylated tau: 37.45 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate ventricular enlargement and normal whole brain volume, which could indicate some atrophy. Biomarkers (Aβ mildly reduced, T-tau moderately elevated, P-tau significantly elevated) suggest Alzheimer's pathology, but cognitive performance (MMSE 28) remains intact.  \n**Diagnosis:** **MCI** (due to biomarker evidence of AD pathology without significant cognitive decline)  \n**Confidence:** **Medium** (cognitive scores are normal, but biomarkers strongly suggest early AD-related changes)",
  "timestamp": "2025-07-26T17:30:38.121056"
}